fda warning letters compounded semaglutide tirzepatide september 2025 15, 2025: Telehealth company must stop implying its GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Trending Topics & Drug Approvals:

Additionally, companies are focusing on differentiating weight loss results in terms of muscle versus fat loss, with those showing minimal muscle loss likely to outperform

Animals C57BL/6J mice and Lepr db ( db/db ) mice were purchased from the Jackson Laboratory (no

Maintenance is most successful when it is treated as an active phase of care, not as the end of treatment

The company has also developed Mounjaro (tirzepatide) as the follow-up product of Trulicity

Patients beginning GLP-1 therapy should be aware that hair shedding, if it occurs, is likely to be uncommon and potentially reversible

As GLP-1 medications affect your metabolism, sugar level, and digestion, using them without a medical prescription is unsafe